S.E. Robinson, Jr.(@SERobinsonJr):Neuralink has registered PRIME2! A newly registered early feasibility study on https://t.co/mtobVzSOBO under NCT07929792 (N1-EFS-300) shows Neuralink will start its first trial to include patients with chronic ischemic stroke, paralysis from a blocked-blood-vessel stroke. Its open enrollment is for 10 people and will use the N1 implant and the R1 surgical robot. The only site listed so far is the University of Miami in Miami, Florida, with Dr. Jonathan Jagid, professor of clinical neurological surgery at the University of Miami Miller School of Medicine, as principal investigator. Primary results are expected around November 2027, while the full study runs through about November 2031.

9hours ago

Neuralink has registered PRIME2! A newly registered early feasibility study on under NCT07929792 (N1-EFS-300) shows Neuralink will start its first trial to include patients with chronic ischemic stroke, paralysis from a blocked-blood-vessel stroke. Its open enrollment is for 10 people and will use the N1 implant and the R1 surgical robot. The only site listed so far is the University of Miami in Miami, Florida, with Dr. Jonathan Jagid, professor of clinical neurological surgery at the University of Miami Miller School of Medicine, as principal investigator. Primary results are expected around November 2027, while the full study runs through about November 2031.